Upregulation of ASIC1a channels in an in vitro model of Fabry disease-Reference-Cited by-同舟云学术

Upregulation of ASIC1a channels in an in vitro model of Fabry disease

Published:2020-11 Issue: Volume:140 Page:104824
ISSN:0197-0186
Container-title:Neurochemistry International
language:en
Short-container-title:Neurochemistry International

Author:

Castellanos Libia Catalina Salinas,Rozenfeld Paula^ORCID,Gatto Rodolfo Gabriel^ORCID,Reisin Ricardo Claudio,Uchitel Osvaldo Daniel,Weissmann Carina^ORCID

Funder

Universidad de Buenos Aires

Takeda Pharmaceutical Company

Publisher

Elsevier BV

Subject

Cell Biology,Cellular and Molecular Neuroscience

Reference42 articles.

1. In vitro inhibition and intracellular enhancement of lysosomal α- galactosidase a activity in fabry lymphoblasts by 1-deoxygalactonojirimycin and its derivatives;Asano;Eur. J. Biochem.,2000

2. Small fiber neuropathy in Fabry disease;Biegstraaten;Mol. Genet. Metabol.,2012

3. A heteromeric Texas coral snake toxin targets acid-sensing ion channels to produce pain HHS Public Access;Bohlen;Nature,2012

4. Activation of extracellular signal-regulated kinase in the anterior cingulate cortex contributes to the induction and expression of affective pain;Cao;J. Neurosci.,2009

5. Activation of acid-sensing ion channel 1a (ASIC1a) by surface trafficking;Chai;J. Biol. Chem.,2010

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Flow Cytometry-Based Assay to Detect Alpha Galactosidase Enzymatic Activity at the Cellular Level;Cells;2024-04-19

2. Redistribution of ASIC1a channels triggered by IL-6: Potential role of ASIC1a in neuroinflammation;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-02

3. Molecular Pathogenesis of Central and Peripheral Nervous System Complications in Anderson–Fabry Disease;International Journal of Molecular Sciences;2023-12-20

4. Segmental Upregulation of ASIC1 Channels in the Formalin Acute Pain Mouse Model;Pharmaceuticals;2022-12-12

5. Recent Advances in Acid-sensitive Ion Channels in Central Nervous System Diseases;Current Pharmaceutical Design;2022-05